钝性创伤性主动脉损伤胸主动脉腔内修复术后远期再干预的系统综述与荟萃分析
该系统综述与荟萃分析检索MEDLINE、EMBASE和Cochrane数据库至2021年6月,纳入11项低质量研究、408例钝性创伤性主动脉损伤行胸主动脉腔内修复术的患者,其中389例存活超过30天。远期再干预率为2.1%(95%CI 0.6-3.9),5年后再干预率为0.1%(95%CI 0.0-1.2)。结论认为胸主动脉腔内修复术远期结果良好,再干预罕见。
要点
- 远期再干预率为2.1%(95%CI 0.6-3.9;11/389例),5年后再干预率为0.1%(95%CI 0.0-1.2;3/389例)。
- 鸟嘴征发生率为38.7%(95%CI 16.4-63.6;I²=86.6%)。
- 远期总生存率为95.6%(95%CI 88.1-99.8;358/389例),仅1例主动脉相关死亡。
核心结论
- 胸主动脉腔内修复术治疗钝性创伤性主动脉损伤远期结果良好,再干预罕见,主动脉再干预倾向于发生在第1年内及第5年后。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE、EMBASE和Cochrane数据库至2021年6月。
- 纳入标准为钝性创伤性主动脉损伤接受胸主动脉腔内修复术且平均随访超过60个月的研究。
- 共纳入11项低质量评估研究,收集408例患者,其中389例存活超过30天纳入分析。
- 采用Freeman-Tukey转化的随机效应模型汇总比例数据。
主要发现
- 平均随访8.2年(95%CI 5.7-10.8;I²=40.2%)。
- 远期再干预率为2.1%(95%CI 0.6-3.9;I²=0.0%;11/389例),5年后再干预率为0.1%(95%CI 0.0-1.2;I²=0.0%;3/389例)。
- 鸟嘴征发生率为38.7%(95%CI 16.4-63.6;I²=86.6%)。
- 30天后左臂跛行发生率为3.1%(95%CI 0.1-8.6;I²=26.9%;11/140例),支架内血栓形成为1.9%(95%CI 0.1-5.2;I²=51.8%;11/389例),内漏为0.5%(95%CI 0.0-1.9;I²=0.0%;5/389例)。
- 内折、闭塞和移位分别报告于389例中的2例、1例和0例;远期总生存率为95.6%(95%CI 88.1-99.8;I²=84.7%;358/389例),仅1例患者发生主动脉相关死亡。
关键数值与推荐
- 远期再干预率2.1%(95%CI 0.6-3.9;I²=0.0%;11/389例)。
- 5年后再干预率0.1%(95%CI 0.0-1.2;I²=0.0%;3/389例)。
- 鸟嘴征38.7%(95%CI 16.4-63.6;I²=86.6%)。
- 远期总生存率95.6%(95%CI 88.1-99.8;I²=84.7%;358/389例)。
临床怎么用
- 胸主动脉腔内修复术治疗钝性创伤性主动脉损伤远期再干预罕见,主动脉再干预倾向于发生在第1年内及第5年后。
局限性
- 纳入的11项研究质量评估为低质量。
- 鸟嘴征汇总比例异质性I²=86.6%。
- 远期总生存率汇总异质性I²=84.7%。
- 平均随访汇总异质性I²=40.2%。
- 左臂跛行汇总比例异质性I²=26.9%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the long-term reinterventions of thoracic endovascular repair (TEVAR) after blunt traumatic aortic injury. METHODS: MEDLINE, EMBASE, and Cochrane databases were interrogated until June 2021. Inclusion criteria were blunt traumatic aortic injury treated with TEVAR and mean follow-up of more than 60 months. A systematic review was conducted and data were pooled using a random effects model of proportions applying the Freeman-Tukey transformation. Late reintervention was the primary outcome. Secondary outcomes were procedure-related complications (endoleak, in-stent thrombosis, occlusion, infolding/collapse, bird-beak, migration, and left arm claudication), overall and aortic-related mortality, and aortic diameter changes. RESULTS: Eleven studies with a low quality assessment were included. Four hundred eight patients were collected and the 389 surviving more than 30 days were included. The mean follow-up was 8.2 years (95% confidence interval [CI], 5.7-10.8; I2 = 40.2%). Late reintervention was 2.1% (95% CI, 0.6-3.9; I2 = 0.0%; 11/389 cases) with 0.1% (95% CI, 0.0-1.2; I2 = 0.0%; 3/389) occurring after 5 years. Bird-beak was identified in 38.7% (95% CI, 16.4-63.6; I2 = 86.6%). Left arm claudication occurring after 30 days was 3.1% (95% CI, 0.1-8.6; I2 = 26.9%; 11/140 cases). In-stent thrombosis was 1.9% (95% CI, 0.1-5.2; I2 = 51.8%; 11/389 cases). Endoleak was 0.5% (95% CI, 0.0-1.9; I2 = 0.0%; 5/389 cases). Infolding, occlusion, and migration were reported in 2 of 389, 1 of 389, and 0 of 389 patients, respectively. Overall late survival was 95.6% (95% CI, 88.1-99.8; I2 = 84.7%; 358/389 patients) and only one patient accounted for aortic related mortality. The increase in proximal and distal aortic diameters was estimated at 2.7 mm (95% CI, 1.2-4.3; I2 = 0.0%) and 2.5 mm (95% CI, 1.1-3.9; I2 = 0.0%), respectively. CONCLUSIONS: TEVAR demonstrates remarkably good long-term results and reinterventions are rarely required. Aortic reinterventions tend to occur within the first and after the fifth year.
引用
- Gennai S, Leone N, Mezzetto L, et al. Systematic review and meta-analysis of long-term reintervention following thoracic endovascular repair for blunt traumatic aortic injury. J Vasc Surg. 2023. PMID: 36754248. doi:10.1016/j.jvs.2023.01.196
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。